不同剂量文拉法辛对卒中后急性期焦虑症患者预后的改善研究

To study the effect of different doses of venlafaxine on the prognosis of patients with acute anxiety disorder after stroke

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2018, 45(1)
作者
作者单位

延安大学咸阳医院神经内六科 ;
延安大学咸阳医院 ;

摘要
【摘要】研究不同剂量文拉法辛对卒中后急性期焦虑症患者预后的改善效果。方法 纳入于我院就诊的86例卒中后急性期焦虑症患者为研究对象,将患者按随机数表法均分为观察组与对照组。两组均给予脑卒中常规药物治疗,观察组另口服大剂量文拉法辛(150mg/d),对照组口服小剂量文拉法辛(75mg/d),疗程8周,均治疗1个疗程。记录两组汉密尔顿焦虑量表(HAMA)评分、美国国立卫生研究院卒中量表(NIHSS)评分、日常生活能力量表(ADL)评分及不良反应发生率。结果 观察组治疗后躯体性焦虑因子、精神性焦虑因子及HAMA总分均低于治疗前(P<0.05),对照组自治疗2周末开始低于治疗前(P<0.05),观察组1、2周末各评分均显著低于对照组(P<0.05)。两组治疗后NIHSS、ADL评分均较治疗前显著改善,且观察组治疗后NIHSS评分低于对照组,ADL评分高于对照组(P<0.05)。两组不良反应发生率比较无统计学意义(P>0.05)。结论 不同剂量文拉法辛治疗卒中后急性期焦虑症均可显著改善患者卒中、焦虑症状,但大剂量改善效果更加明显且起效更快,不良反应并未显著增加,具有更好的应用前景。
Abstract
【Abstract】Objective To study the effect of different doses of venlafaxine on the prognosis of patients with acute anxiety disorder after stroke. Method 86 patients with acute anxiety in our hospital were selected as the subjects. The patients were randomly divided into observation group and control group. Two groups were given routine drug in the treatment of stroke. The observation group was given a large dose of venlafaxine 150mg/d, while the control group was treated with small dose of 75mg/d for 8 weeks. All the patients were treated for 1 courses with 8 weeks. The two groups of Hamilton Anxiety Scale (HAMA) score, the National Institutes of Health Stroke Scale (NIHSS) score, the daily living ability scale (ADL) score and the incidence of adverse reactions were recorded. Result After treatment, the scores of somatization, anxiety and HAMA in the observation group were lower than those before treatment (P<0.05). After treatment for 2 weeks, the scores of the control group were lower than those before treatment (P<0.05). The observation group was significantly lower than the control group at the end of 1 and 2 weeks (P<0.05). Compared with before treatment, NIHSS and ADL scores of the two groups after treatment were significantly improved (P<0.05). The NIHSS score of the observation group was lower than that of the control group after treatment, and the ADL score was higher than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion Different doses of venlafaxine in the treatment of acute post-stroke anxiety disorder can significantly improve the patients stroke, anxiety symptoms, but the effect of large dose improvement is more obvious and faster onse. Large dose adverse reactions did not increase significantly and it has better application prospect.
关键词
【关键词】 不同剂量;文拉法辛;卒中;急性期焦虑症;预后
KeyWord
【Keywords】Different dosage, Venlafaxine, Stroke, Acute anxiety disorder, Prognosis
基金项目
页码 137-140
  • 参考文献
  • 相关文献
  • 引用本文

赵志茹,赵雄飞,张维,郝锋利*. 不同剂量文拉法辛对卒中后急性期焦虑症患者预后的改善研究 [J]. 国际精神病学杂志. 2018; 45; (1). 137 - 140.

  • 文献评论

相关学者

相关机构